Michael Gruet

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma

E. Want, H. Keun, D. Carling, 2022, Nature communications.

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma

I. McNeish, H. Keun, A. Nijhuis, 2023, bioRxiv.

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma

E. Want, H. Keun, D. Carling, 2020, Nature Communications.

Chemical tools for profiling the intracellular ADP-ribosylated proteome

Edward W. Tate, A. Siskos, D. Conole, 2023, bioRxiv.